Meta-analysis of rates of drop-out from psychosocial treatment among persons with schizophrenia spectrum disorder

Schizophrenia Research

Volumn 121, Issue 1-3, 2010, Pages 266-270

  Villeneuve, K ^a   Potvin, S ^a   Lesage, A ^a   Nicole, L ^a  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

Compliance; Drop out; Psychosocial treatment; Schizophrenia

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE DURATION; EVIDENCE BASED PRACTICE; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SEX RATIO; TREATMENT DURATION; BIBLIOGRAPHIC DATABASE; FEMALE; MALE; PATIENT COMPLIANCE; PATIENT DROPOUTS; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

DATABASES, BIBLIOGRAPHIC; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PATIENT DROPOUTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 77955055979     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.04.003     Document Type: Article

References (14)

1. Bechdolf A., Kohn D., Knost B., Pukrop R., Klosterkotter J. A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24months. Acta Psychiatrica Scandinavica 2005, 112(3):173-179.
2. Borenstein M., Rothstein H. Comprehensive Meta-Analysis: A Computer Program for Research Synthesis 1999, Biostats, Englewood, New Jersey.
3. Centorrino F., Hernan M.A., Drago-Ferrante G., Rendall M., Apicella A., Langar G., Baldessarini R.J. Factors associated with noncompliance with psychiatric outpatient visits. Psychiatric Services 2001, 52:378-380.
4. Cramer J.A., Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatric Services 1998, 49:196-201.
5. Degmecić D., Pozgain I., Filaković P. Psychoeducation and compliance in the treatment of patients with schizophrenia. Collegium Antropologicum 2007, 31(4):1111-1115. (Dec).
6. DerSimonian R., Laird N.M. Meta-analysis in clinical trials. Controlled Clinical Trial 1988, 7(3):177-188.
7. Geddes J., Freemantle N., Harrison P., Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 2000, 321:1371-1376.
8. Kreyenbuhl J., Nossel I.R., Dixon L.B. Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literature. Schizophrenia Bulletin 2009, 2:1-8.
9. Leandro, G., 2005. Meta-analysis in Medical Research: The handbook for the understanding and practice of meta-analysis, Italy: BMJ Books, Blackwell Publishing: 97 pp.
10. Lecomte T., Spidel A., Leclerc C., MacEwan W.G., Greaves C., Bentall P.R. Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosis. Schizophrenia Research 2008, 102:295-302.
11. Lehman F.A., Kreyenbuhl J., Buchanan W.R., Dickerson B.F., Dixon B.L., Goldberg L.D. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations. Schizophrenia Bulletin 2003, 30:193-217.
12. Lieberman J.A., Hsiao H.K. Interpreting the results of the CATIE study. Psychiatric Services 2006, 57:139.
13. Meyer M.J. Strategies for the long-term treatment of schizophrenia: real-world lessons from the CATIE trial. Journal of Clinical Psychiatry 2007, 68:28-33.
14. Rosenheck R., Chang S., Choe Y., Cramer J., Xu W., Thomas J., Henderson W., Charney D. Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol. Journal of Clinical Psychiatry 2000, 61:382-386.